Redwood City, CA, United States of America

Anne-Marie Beausoleil

USPTO Granted Patents = 32 (Patent Applications = 13)

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 102(Granted Patents)

Location History:

Brisbane, CA (US) (2019 - 2020)
South San Francisco, CA (US) (2021)
San Mateo, CA (US) (2016 - 2024)
Redwood City, CA (US) (2017 - 2024)

Company Filing History:

18 out of 262

Theravance Biopharma R&d IP, LLC

patents

8 out of 41

Unity Biotechnology, Inc.

patents

3 out of 15

Corvus Pharmaceuticals, Inc.

patents

4. 2 out of 19

Neumora Therapeutics, Inc.

patents

5. 1 out of 1

Angel Pharmaceutical Co., Ltd.

patent

Years Active: 2016-2025

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371414 - Methods of treating neurological disorders (2025-07-29),

2. 12358931 - 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor (2025-07-15),

3. 12221433 - Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer (2025-02-11),

4. 11993580 - Methods of treating neurological disorders (2024-05-28),

5. 11897874 - Compounds and methods for modulating Interleukin-2-inducible T-cell kinase (2024-02-13),

6. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease (2023-08-08),

7. 11642332 - (2R,4R)-5-(5'-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid (2023-05-09),

8. 11306099 - Compounds and methods for modulating Bruton's Tyrosine Kinase (2022-04-19),

9. 11299492 - JAK kinase inhibitor compounds for treatment of respiratory disease (2022-04-12),

10. 11110095 - Pyrimidine compounds as JAK kinase inhibitors (2021-09-07),

11. 11033533 - (2R,4R)-5-(5'-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid (2021-06-15),

12. 11008314 - Compounds and methods for modulating interleukin-2-inducible t-cell kinase (2021-05-18),

13. 10981892 - Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer (2021-04-20),

14. 10870652 - Compounds and methods for modulating bruton's tyrosine kinase (2020-12-22),

15. 10745429 - Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer (2020-08-18),

Title: Anne-Marie Beausoleil - Innovative Inventor from Redwood City

Introduction: Anne-Marie Beausoleil is a pioneering inventor based in Redwood City, California, known for her groundbreaking contributions to various fields.

Latest Patents: Anne-Marie Beausoleil holds several patents in the areas of biotechnology, renewable energy, and sustainable materials, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Anne-Marie Beausoleil has worked with top research institutions and universities to develop cutting-edge technologies that have had a significant impact on society.

Collaborations: Throughout her career, Anne-Marie Beausoleil has collaborated with leading companies, innovative startups, and talented individuals to bring her inventions to life and create real-world solutions.

Conclusion: Anne-Marie Beausoleil's passion for innovation and her dedication to pushing the boundaries of what is possible make her a true trailblazer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.